Research Reagents for SARS-CoV-2 Omicron Variant

Sino Biological, Inc. (https://www.sinobiological.com; SHE: 301047) announced today that it has launched a panel of research reagents for the newly identified Omicron variant (B.1.1.529) of the SARS-CoV-2 virus

Related Keywords

China ,Beijing ,Shenzhen ,Guangdong ,Jie Zhang ,Shenzhen Stock Exchange ,Sino Biological Inc ,Sino Biological Inc Dec ,From Sino Biological Inc Dec ,Sino Biological ,Omicron Spike ,Private Securities Litigation Reform ,Shenzhen Stock ,Reagents ,Research ,Cars ,Ars Cov 2 ,Antibodies ,Ntibody ,Ntigen ,Essay ,Pandemic ,Protein ,Pseudovirus ,Spike Protein ,Virus ,